Slate of Candidates for Fiscal Year 2026

The Official Delegate for each DCAT Member Company is requested to respond to this ballot by Friday, October 17, 2025.

The following slate of candidates has been recommended by the DCAT Leadership Development Committee for the 2026 fiscal year, which begins on November 1, 2025.

EXECUTIVE COMMITTEE, Board of Directors (1 Year Term):

PRESIDENT: Kelsey Achenbach, Vice President Pharma, Health Nutrition & Care (HNC), dsm-firmenich
FIRST VICE PRESIDENT: Ken Seufert, Chief Executive Officer, JRS Pharma LP
SECOND VICE PRESIDENT: Michael Semo, Associate Vice President, Eli Lilly & Company
THIRD VICE PRESIDENT: Sucheth Davuluri, Vice Chairman & CEO, Neuland Laboratories LTD

DIRECTOR, Board of Directors (1 Year Term):

Christopher Conway, Chief Executive Officer, Bio X Cell
Pierfrancesco Morosini, President and Chief Executive Officer, ICROM
Allison Vavala, Senior Director, Business Development, Flamma
Louis Weber, Vice President of Business Development, Mikart LLC
Athelney Woolnough, Director, Business Development and Key Account Management, Boehringer Ingelheim Biopharmaceuticals GmbH